Pérdida de grasa y metabolismo Pérdida de grasa

Orforglipron

Also known as: LY-3502970

Agonista GLP-1 oral (sin inyección).

25–68 h

Common Protocol

Rangos citados: 3–36 mg al día (oral).

Science & Mechanism

Agonista oral del receptor GLP-1 que logra pérdida de peso significativa sin inyecciones ni refrigeración.

Members feature

Join the community from $7/mo to unlock it.

See plans
Legal Notice: This information is strictly educational and is based on scientific and research literature. For research purposes only. The protocols, dose ranges and variations reflect figures cited in scientific discussions and do not constitute medical recommendations. Always consult a qualified healthcare professional.

Related Peptides